- Health
Brain Innovation Days 2026
The Brain Innovation Days 2026 cover recent advances, challenges and opportunities in the field through talks, panel discussions, interactive sessions and networking.
Read moreEvents
This was 2 years ago
Brussels
The Innovative Health Initiative will hold a brokerage event in Brussels on 12 & 13 November 2024.
The aim of the event is to provide people interested in IHI Call 9 for proposals with the opportunity to network face-to-face and start forming consortia. There will also be pitching sessions and poster sessions to give research organisations, patient groups and companies the chance to showcase their capabilities. Find the detailed agenda of the event here.
More information and registration for the brokerage event on the IHI website.
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
The Brain Innovation Days 2026 cover recent advances, challenges and opportunities in the field through talks, panel discussions, interactive sessions and networking.
Read moreThis hybrid information day is organised by the European Commission and looks at Horizon Europe Cluster 5 funding opportunities in climate, energy and mobility under the 2027 call topics. Onsite participants can ask questions directly or through Slido, and online participants can also use the Q&A tool. Questions are expected to be accepted...
Read moreAn overview of the upcoming EIC funding opportunities and new features introduced in 2027. Speakers from the European Innovation Council and SMEs Executive Agency (EISMEA) and the Directorate-General for Research and Innovation (DG RTD) of the European Commission will present an overview of the main EIC funding schemes: EIC Pathfinder:...
Read moreThis round table event looks at how regional brain health ideas can reach a larger audience and seeks to encourage dialogue between innovation and implementation.
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.